All PlansCoverageMedium impact
Laboratory Tests Post Transplant and for Heart Failure
Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Internal Medicine, Family Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
This policy provides comprehensive coverage guidelines for laboratory biomarker tests (BNP, NT-proBNP, and ST2) used in heart failure diagnosis, prognosis, and management, as well as post-transplant monitoring. The policy establishes medical necessity criteria and coverage parameters for these specialized cardiac biomarkers.
Action Required
Review current heart failure and post-transplant laboratory billing practices to ensure alignment with new biomarker coverage criteria. Verify that BNP, NT-proBNP, and ST2 testing documentation meets the medical necessity requirements outlined in policy A.2.01.68. Update prior authorization workflows if required for these specialized cardiac biomarkers.